UnitedHealth (UNH) EVP Erin Mcsweeney Buys 48 Shares

Insider Buying and Selling at UnitedHealth Group Incorporated

On June 23, 2026, Erin Mcsweeney, the Executive Vice President and Chief People Officer of UnitedHealth Group Incorporated (NYSE: UNH), bought 48 shares of the company at a price of $415.53 per share. This purchase is valued at approximately $19,800. The transaction reflects ongoing confidence from company insiders as they actively engage in buying shares.

Other Insiders Join the Buying Trend

On the same day, several other executives at UnitedHealth Group also made purchases. Dennis Stankiewicz, the Chief Accounting Officer, bought 51 shares, while Conway Patrick Hugh, the CEO of Optum, purchased 83 shares. Kristen Gil acquired 8 shares, Scott Gottlieb bought 3 shares, John Noseworthy added 41 shares, and Noel Timothy John, the CEO of UHC, acquired 76 shares. This collective insider activity suggests a strong belief in the company's future performance and stability.

Stock Performance and Recent Trends

As of June 23, 2026, UnitedHealth Group's stock traded at $415.53, which is above its 50-day moving average of $387.35. The stock also remains well above its 52-week low of $255.97 and is approaching its 52-week high of $461.62. This positioning indicates a robust performance in the current market environment.

Analysts Set New Price Targets

Analysts maintain a generally positive outlook on UnitedHealth Group. On October 16, 2026, JP Morgan reiterated an 'Overweight' rating with a price target of $524.00, while TD Cowen reiterated a 'Hold' rating with a target of $402.00 on October 15. Piper Sandler and Barclays also maintain 'Overweight' ratings with targets of $504.00 and $440.00, respectively. The consensus among analysts is a 'buy' rating, with a mean price target of $477.04, indicating strong confidence in the company's prospects.

What UnitedHealth Group Incorporated Does

UnitedHealth Group operates as a health care company, providing a range of services through its segments, including Optum Health, Optum Insight, and UnitedHealthcare. This insider purchasing activity coincides with the company's strategic initiatives and ongoing market presence, illustrating confidence from its leadership.

What's Next for UnitedHealth Group

Investors will be looking forward to the next earnings report scheduled for January 26, 2027. As always, it's important to remember that the recent insider transactions reflect past holdings and may not indicate current positions. With analysts maintaining a positive outlook, UnitedHealth Group appears to be well-positioned in the healthcare market.